Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings

Download

index.pdf

Date

2014-07-01

Author

Gungor, Bilgi
Yagci, Fuat Cem
GÜRSEL, İHSAN
Gürsel, Mayda

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

13
views

17
downloads

Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon alpha (IFN alpha) stimulating activity into a robust Type I interferon inducer with potent vaccine adjuvant activity.

Subject Keywords

CpG ODN, Type I interferon, Vaccine adjuvant

URI

https://hdl.handle.net/11511/42937

Journal

ONCOIMMUNOLOGY

DOI

https://doi.org/10.4161/21624011.2014.950166

Collections

Department of Biology, Article

Citation Formats

B. Gungor, F. C. Yagci, İ. GÜRSEL, and M. Gürsel, “Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings,” ONCOIMMUNOLOGY, vol. 3, no. 7, pp. 0–0, 2014, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/42937.